Target intelligence / Profile preview

T cell receptor beta variable 8-1 (pseudogene) (TRBV8-1)

Target
TRBV8-1
Molecular classification
Pseudogene, T cell receptor gene segment
01

Overview

T cell receptor beta variable 8-1 (TRBV8-1) is a **pseudogene** in the human genome, classified as part of the T cell receptor beta variable (TRBV) gene family[1][5]. The TRBV genes typically encode the variable domain of the T cell receptor beta chain, contributing to the diversity of antigen recognition by T lymphocytes[6]. However, as a pseudogene, TRBV8-1 does not produce a functional protein product and is not itself a component of the T cell receptor complex[1][5]. The functional T cell receptor (TCR) is a membrane-bound immunoglobulin-like receptor present on T cells, crucial for antigen recognition and T cell-mediated immune responses[6]. Functional polymorphisms in other TRBV genes have been implicated in autoimmunity and immune-related adverse events, but pseudogenes like TRBV8-1 are generally not directly targeted for therapy or used as biomarkers[3]. Alternative names for TRBV8-1 include TRBV81, TCRBV30S1P, and TCRBV8S1P[1][5]. Its characterization as a pseudogene means it is not considered a therapeutic or diagnostic target.

Other names
TRBV81TCRBV30S1PTCRBV8S1P
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it does not encode a functional protein)
04

Disease associations

Other (no direct role; pseudogene status means it does not participate in disease as a functional receptor, but related loci may have roles in autoimmunity or immune diversity)

Beyond the preview

Go deeper on T cell receptor beta variable 8-1 (pseudogene) (TRBV8-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 8-1 (pseudogene) (TRBV8-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call